Polymorphisms in NRGN are associated with schizophrenia, major depressive disorder and bipolar disorder in the Han Chinese population.

[1]  Jiawei Shen,et al.  The NVL gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population , 2015, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2]  Jiawei Shen,et al.  The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population. , 2015, Journal of affective disorders.

[3]  R. Pan,et al.  Influence of NRGN rs12807809 polymorphism on symptom severity in individuals with schizophrenia in the Han population but not the Zhuang population of south China , 2015, Acta Neuropsychiatrica.

[4]  Jiawei Shen,et al.  Genetic association of ACSM1 variation with schizophrenia and major depressive disorder in the Han Chinese population , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[5]  Jiawei Shen,et al.  SNAP25 is associated with schizophrenia and major depressive disorder in the Han Chinese population. , 2015, The Journal of clinical psychiatry.

[6]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[7]  Jianxin Shi,et al.  Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.

[8]  H. Kazui,et al.  Functional genetic variation at the NRGN gene and schizophrenia: Evidence from a gene‐based case–control study and gene expression analysis , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[9]  Shih-Fen Chen,et al.  Genetic and functional analysis of the gene encoding neurogranin in schizophrenia , 2012, Schizophrenia Research.

[10]  M. Rietschel,et al.  Risk variant for schizophrenia in the neurogranin gene impacts on hippocampus activation during contextual fear conditioning , 2011, Molecular Psychiatry.

[11]  D. Grozeva,et al.  Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. , 2011, Human molecular genetics.

[12]  Tao Li,et al.  Common Variants in Major Histocompatibility Complex Region and TCF4 Gene Are Significantly Associated with Schizophrenia in Han Chinese , 2010, Biological Psychiatry.

[13]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[14]  Pall I. Olason,et al.  Common variants conferring risk of schizophrenia , 2009, Nature.

[15]  M C O'Donovan,et al.  The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia , 2009, Molecular Psychiatry.

[16]  Jianxin Shi,et al.  Common variants on chromosome 6p22.1 are associated with schizophrenia , 2009, Nature.

[17]  K. Frazer,et al.  Human genetic variation and its contribution to complex traits , 2009, Nature Reviews Genetics.

[18]  S. Gabriel,et al.  Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder , 2008, Nature Genetics.

[19]  F. Huang,et al.  Long-term enrichment enhances the cognitive behavior of the aging neurogranin null mice without affecting their hippocampal LTP. , 2007, Learning & memory.

[20]  R. Kessler,et al.  Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. , 2007, Archives of general psychiatry.

[21]  S. Ghaemi.  Paradigms of psychiatry: eclecticism and its discontents , 2006, Current opinion in psychiatry.

[22]  M. Daly,et al.  Transferability of tag SNPs in genetic association studies in multiple populations , 2006, Nature Genetics.

[23]  Kevin G. Broadbelt,et al.  Evidence of altered neurogranin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex , 2006, Schizophrenia Research.

[24]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[25]  N. Craddock,et al.  The genetics of schizophrenia and bipolar disorder: dissecting psychosis , 2005, Journal of Medical Genetics.

[26]  Lin He,et al.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci , 2005, Cell Research.

[27]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[28]  J. Coyle,et al.  Glutamatergic mechanisms in schizophrenia. , 2003, Annual review of pharmacology and toxicology.

[29]  Olga V. Demler,et al.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.

[30]  P. Sham,et al.  The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. , 2003, Archives of general psychiatry.

[31]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[32]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G Kalsi,et al.  Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. , 2001, American journal of human genetics.

[34]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[35]  P. Sullivan,et al.  Genetic epidemiology of major depression: review and meta-analysis. , 2000, The American journal of psychiatry.

[36]  I. Gottesman,et al.  Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. , 2000, American journal of medical genetics.

[37]  Nicholas Lange,et al.  D-serine added to antipsychotics for the treatment of schizophrenia , 1998, Biological Psychiatry.

[38]  Carol A. Tamminga,et al.  Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.

[39]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[40]  Tao Li,et al.  CACNA1C, schizophrenia and major depressive disorder in the Han Chinese population. , 2014, The British journal of psychiatry : the journal of mental science.

[41]  Janice M. Fullerton,et al.  Common variant at 16p11.2 conferring risk of psychosis , 2014, Molecular Psychiatry.

[42]  M. Rietschel,et al.  The effect of neurogranin on neural correlates of episodic memory encoding and retrieval. , 2013, Schizophrenia bulletin.

[43]  Tao Li,et al.  A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn) , 2009, Cell Research.

[44]  J. Bernal,et al.  The Human RC3 Gene Homolog, NRGN Contains a Thyroid Hormone-Responsive Element Located in the First Intron* * This work was supported by grants from Fundación Ramon Areces and DGICYT (PM95-0019). , 1999, Endocrinology.